Home NDC 60505-6414 IVRA
Product NDC 60505-6414
11-digit product format 605056414
Labeler code 60505
Product ID 60505-6414_1aaa2d67-c709-f01c-026d-0eaa8f47c5d1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name melphalan HCl
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Apotex Corp
Application NDA217110
Marketing category NDA
Marketing start 2025-05-09
Substance MELPHALAN HYDROCHLORIDE
Active strength 90 mg/mL
Pharmacologic classes Alkylating Activity [MoA], Alkylating Drug [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217110-001 IVRA MELPHALAN HYDROCHLORIDE EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217110-001 10537520 2036-06-29 Drug product 2023-09-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217110-001 MELPHALAN HYDROCHLORIDE EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217110-001 MELPHALAN HYDROCHLORIDE EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N217110-001 MELPHALAN HYDROCHLORIDE EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N217110-001 MELPHALAN HYDROCHLORIDE EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N217110-001 MELPHALAN HYDROCHLORIDE EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N217110-001 MELPHALAN HYDROCHLORIDE EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N217110-001 MELPHALAN HYDROCHLORIDE EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N217110-001 MELPHALAN HYDROCHLORIDE EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 9b2671bbb829…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217110-001 IVRA EQ 90MG BASE/ML (EQ 90MG BASE/ML) SOLUTION / INTRAVENOUS RLD, RS 2023-08-18 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 9b2671bbb829…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217110-001 10537520 2036-06-29 Drug product 2023-09-01 a50c72e98297…
Additional Listing Data#
Finished product Yes
Brand name base IVRA
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MELPHALAN HYDROCHLORIDE 90 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1VXP4V453T Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2708998 Internal RxNorm lookup 2709003 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 60505-6414-1 IVRA 1 in 1 CARTON INJECTION, SOLUTION 1 5 60505-6414-1 IVRA 3 mL in 1 VIAL, MULTI-DOSE INJECTION, SOLUTION 3 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 60505-6414 IVRA (MELPHALAN HCL) INJECTION, SOLUTION [APOTEX CORP] 4 Current NDC, 2 package rows 20250511_c23e868a-dc62-2181-5099-76c9226602b2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join IVRA MELPHALAN HCL Apotex Corp c23e868a-dc62-2181-5099-76c9226602b2 2025-09-04 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 217110 application number: NDA217110 ndc (product): 60505-6414
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 60505-6414-1 60505641401 1 VIAL, MULTI-DOSE in 1 CARTON (60505-6414-1) / 3 mL in 1 VIAL, MULTI-DOSE 2025-05-09 No No Current